Marvin & Palmer Associates’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
Marvin & Palmer Associates's MRK Position: Q3 2022 in Review
Marvin & Palmer Associates sold out of Merck (MRK) in Q3 2022, closing a stake of 105,965 shares — an estimated $9.66M sold.
Marvin & Palmer Associates first reported a position in MRK in Q2 2014 and held it in 7 quarters. The position peaked at $9.66M in Q2 2022. 2,990 funds tracked by Wall St. Rank hold MRK as of Q3 2022.
- Marvin & Palmer Associates reported no remaining Merck position as of Q3 2022 after selling out during the quarter.
- Marvin & Palmer Associates sold 105,965 Merck shares in Q3 2022, an estimated $9.66M.
- Marvin & Palmer Associates first reported a position in Merck in Q2 2014 and held it in 7 quarters.
- Marvin & Palmer Associates's Merck position peaked at $9.66M in Q2 2022.
- 2,990 funds tracked by Wall St. Rank held Merck as of Q3 2022.
Based on Marvin & Palmer Associates's 13F filing for Q3 2022, filed 14 Nov 2022.